Andrew Schade

Andrew Schade is a distinguished medical fellow at Eli Lilly and Company, specializing in clinical pathology, hematology, and immunology, with a focus on biomarker development. They led an internal CAP-accredited CLIA laboratory, researching disease pathobiology and advancing therapeutic approaches. Prior to this, Andrew served as Medical Director of the Hemostasis and Thrombosis Laboratory at Cleveland Clinic. Andrew earned a PhD in Immunology and an MD from Case Western Reserve University, followed by a residency in Clinical Pathology at Cleveland Clinic.